Geron Corporation, a Bay Area biotech company that's ramping up sales of its first commercial drug, announced on Thursday ...

Sanofi is back with its second pact of the day, this time announcing a licensing deal for a South Korean biotech’s antibody ...

Findings provide scientific insights into the contributions of IDO1 and PD-L1 vaccination to PD-1 blockade for the treatment of metastatic melanomaFive-year analysis of median progression free ...

Chai Discovery, an OpenAI-supported biotech startup, has raised $130 million in a Series B round, reaching a valuation of ...

Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could ...

Fortress and its majority-owned subsidiary, Cyprium Therapeutics, said the FDA has accepted an NDA resubmission for CUTX-101, or copper histidinate, a treatment for children who suffer from Menkes ...

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's ...

As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look ...

Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...